Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity
Department of Medicine, Division of Diabetes; Department of Medicine, Division of Endocrinology and Metabolism
Allergy and Immunology | Endocrinology, Diabetes, and Metabolism | Immunology and Infectious Disease | Life Sciences | Medicine and Health Sciences
The use of "humanized" mice represents an appealing translational model for studies of the pathogenesis of immune-mediated diseases and for the evaluation of potential therapeutics. The utility of humanized mice depends on their ability to model the human immune system with high fidelity, and, in this respect, previous models have fallen short. The recently developed NOD-scid Il2rgamma(null) mouse, however, exhibits greatly enhanced ability to support the engraftment of human peripheral blood mononuclear cells. Herein, we describe the challenges of recapitulating human immunity in humanized mice and features of NOD-scid Il2rgamma(null) mice that help overcome them.
DOI of Published Version
Ann N Y Acad Sci. 2007 Apr;1103:90-3. Epub 2007 Mar 21. Link to article on publisher's site
Annals of the New York Academy of Sciences
King MA, Pearson T, Shultz LD, Leif JH, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Mordes JP, Rossini AA, Greiner DL. (2007). Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity. Morningside Graduate School of Biomedical Sciences Student Publications. https://doi.org/10.1196/annals.1394.011. Retrieved from https://escholarship.umassmed.edu/gsbs_sp/503